Evonik 1Q Results Don't Surprise -- Market Talk
0718 GMT - Evonik's reiterated adjusted Ebitda guidance of EUR1.7 billion-EUR2 billion compares with Jefferies' EUR1.94-billion estimate and market consensus of EUR2.00 billion, the brokerage notes. T
UPDATE 1-Evonik Expects Q2 Core Profit in Line With Q1, Confirms 2024 Outlook
Shareholders in Evonik Industries (ETR:EVK) Are in the Red If They Invested Three Years Ago
EVONIK INDUSTRIES AG UNSP ADR EACH REPR 2 ORD To Go Ex-Dividend On June 6th, 2024 With 0.63449 USD Dividend Per Share
March 7th - $EVONIK INDUSTRIES AG UNSP ADR EACH REPR 2 ORD(EVKIY.US)$ is trading ex-dividend on June 6th, 2024. Shareholders of record on June 6th, 2024 will receive 0.63449 USD dividend per share
Evonik Industries Full Year 2023 Earnings: Misses Expectations
Evonik Plans to Cut 2,000 Jobs, Sees No Economic Recovery This Year
UPDATE 1-European Shares Scale Another Record High on Tech Support
Evonik Says Recovery Unlikely in 2024, Plans 2,000 Job Cuts
Are Investors Undervaluing Evonik Industries AG (ETR:EVK) By 34%?
Acrylic Resin Market Size to Grow by USD 5.48 Billion From 2022 to 2027, Llnex GMBH, Anhui Elite Industrial Co. Ltd., Arkema Group, and MORE to Emerge as Key Players- Technavio
The acrylic resin market size is expected to grow by USD 5.48 billion from 2022 to 2027.
EVONIK INDUSTRIES AG UNSP ADR EACH REPR 2 ORD To Go Ex-Dividend On June 1st, 2023 With 0.62144 USD Dividend Per Share
May 31st - $EVONIK INDUSTRIES AG UNSP ADR EACH REPR 2 ORD(EVKIY.US)$ is trading ex-dividend on June 1st, 2023. Shareholders of record on June 2nd, 2023 will receive 0.62144 USD dividend per share
Evonik gets US government funding for $220M lipid production site for mRNA therapies
Germany chemical maker Evonik Industries (OTCPK:EVKIY) (OTCPK:EVKIF), with funding from the U.S. government, will spend a total $220M to build a new lipid production facility for mRNA-based therapies
No Data